5-HT1B and 5-HT1D receptors in the human trigeminal ganglion: Co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase

Brain Research

Volumn 909, Issue 1-2, 2001, Pages 112-120

  Hou, Mingyan ^a   Kanje, Martin ^b   Longmore, Jenny ^c   Tajti, Janos ^d   Uddman, Rolf ^a   Edvinsson, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^d UNIVERSITY OF SZEGED   (Hungary)

Author keywords

5 HT1B and 5 HT1D receptors; Calcitonin gene related peptide; Nitric oxide synthase and immunocytochemistry; Substance P

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NITRIC OXIDE SYNTHASE; RECEPTOR SUBTYPE; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SUBSTANCE P;

ADULT; AGED; ARTICLE; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR OCCUPANCY; TRIGEMINUS GANGLION;

AGED; AGED, 80 AND OVER; CALCITONIN GENE-RELATED PEPTIDE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEURONS, AFFERENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, SEROTONIN; SEROTONIN; SUBSTANCE P; TRIGEMINAL GANGLION;

EID: 0035800636     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02645-2     Document Type: Article

References (46)

1. Sub-populations of smaller diameter trigeminal primary afferent neurons defined by expression of calcitonin gene-related peptide and the cell surface oligosaccharide recognized by monoclonal antibody LA4
2. Brain stem terminations of the trigeminal and upper spinal innervation of the cerebrovascular system
3. 1D receptor mRNA differential co-localization with peptide mRNA in the guinea pig trigeminal ganglion
4. Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels
5. Evidence for the presence of 5-HT1B receptor messenger RNA in neurons of the rat trigeminal ganglia
6. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion
7. 1 receptor activation
8. On migraine pathophysiology
9. Neuropeptides in migraine and cluster headache
10. The tentorial nerves and localisation of intracranial pain in man
11. Substance P-like immunoreactivity in the human trigeminal ganglion
12. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies
13. The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes in human and cats
14. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
15. Expression of mRNA for the serotonin 5-Hydroxytryptamine 1Dβ receptor subtype in human and bovine cerebral arteries
16. Neurogenic inflammation: Relation to novel antimigraine drugs
17. Mode of action of the anti-migraine drug sumatriptan
18. Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P, and calcitonin gene-related peptide in human middle meningeal arteries: Comparison with cerebral and temporal arteries
19. Serotonin modulates substance P-induced plasma extravasation and vasodilatation in rat skin by an action through capsaicin-sensitive primary afferent nerves
20. Nitric oxide synthase inhibition in migraine
21. 1-receptor. Support for the NO hypothesis of migraine
22. Advances in migraine therapy - 5-HT receptor subtype-specific agonist drugs
23. 1D immunoreactivity within the human trigemino-cerebrovascular system: Implications for the discovery of new antimigraine drugs
24. Autoradiographic mapping of receptors and recognition sites for established and putative antimigraine drugs
25. Release of the predicted calcitonin gene-related peptide from cultured rat trigeminal ganglion cells
26. Two distinct calcitonin gene-related peptide-containing peripheral nervous system: Distribution and quantitative differences between iris and cerebral artery with special reference to substance P
27. Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry
28. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine
29. 1B receptors in human cerebral arteries: Pharmacological characterization with immunocytochemistry
30. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques
31. Nitric oxide is a key molecule in migraine and other vascular headaches
32. Experimental studies on headache. Pain sensitive structures of the head and their significance in headache
33. 1F receptor activation
34. Selective 5-HT1Dα serotonin receptor gene expression in trigeminal ganglia: Implications for antimigraine drug development
35. Nitric oxide involvement in the trigeminal hyperalgesia in diabetic rats
36. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
37. Trigeminal origin of beta-preprotachykinin products in feline pial blood vessels
38. Neurotransmitter candidates of somatosensory primary afferent fibres
39. Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in Dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats
40. 1D-receptor specific antibodies as unique research tools
41. Histamine application to the nasal mucosa induces release of calcitonin gene-related peptide and substance P from peripheral terminals of trigeminal ganglion: A morphological study in the guinea pig
42. Nitric oxide theory of migraine
43. Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: Trigeminal origin and co-existence with substance P
44. Neuronal pathways to the rat middle meningeal artery revealed by retrograde tracing and immunocytochemistry
45. Expression of serotonin receptor mRNAs in blood vessels
46. Expression of the 5-HT1B receptor by subtypes of rat trigeminal ganglion cells